Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation

Takuyu Hashiguchi1, Shingo Arakawa1, Shogo Takahashi1

  • 1Pharmacogenetics Section (T.H., S.A., T.S., M.N.), Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709; and Laboratory of Metabolism (S.T., F.J.G.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Nuclear receptors utilize a conserved phosphorylation motif to regulate protein degradation. Farnesoid X receptor (FXR) phosphorylation at Ser154 controls its activity and degradation via proteasome or nonproteasome pathways.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Nuclear receptors are crucial transcriptional regulators.
  • Their activity is tightly controlled by post-translational modifications, including phosphorylation.
  • Proteolytic degradation is a key mechanism for regulating nuclear receptor levels.

Purpose of the Study:

  • To investigate the role of a conserved phosphorylation motif in nuclear receptor degradation.
  • To elucidate the regulatory mechanism of farnesoid X receptor (FXR) stability and activity.

Main Methods:

  • Comparative analysis of 11 human nuclear receptor amino acid sequences.
  • Site-directed mutagenesis to create a phosphomimetic FXR S154D mutant.
  • Reporter gene assays in COS-1 cells to assess FXR binding and trans-activation.
  • Western blotting to detect FXR phosphorylation and degradation.
  • VRK1 knockdown experiments using siRNA.
  • In vivo phosphorylation studies in ligand-treated mice.

Main Results:

  • A conserved phosphorylation motif in the DNA-binding domain of nuclear receptors was identified as an intramolecular degradation signal.
  • The phosphomimetic FXR S154D mutant exhibited impaired DNA binding and trans-activation, along with rapid degradation.
  • Ligand treatment increased Ser154 phosphorylation of ectopically expressed FXR in COS-1 cells.
  • Knockdown of nuclear vaccinia-related kinase 1 (VRK1) significantly reduced FXR Ser154 phosphorylation.
  • FXR Ser154 phosphorylation was observed in the nucleus of mouse hepatocytes specifically after ligand treatment.

Conclusions:

  • FXR Ser154 phosphorylation acts as a rheostat, modulating receptor activation and subsequent degradation.
  • This phosphorylation event controls FXR levels and activity through proteasome and nonproteasome degradation pathways.
  • The findings reveal a novel regulatory mechanism for nuclear receptor homeostasis and function.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.8K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
12.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K